EP0391997A4 - Vaccine - Google Patents

Vaccine

Info

Publication number
EP0391997A4
EP0391997A4 EP19890910995 EP89910995A EP0391997A4 EP 0391997 A4 EP0391997 A4 EP 0391997A4 EP 19890910995 EP19890910995 EP 19890910995 EP 89910995 A EP89910995 A EP 89910995A EP 0391997 A4 EP0391997 A4 EP 0391997A4
Authority
EP
European Patent Office
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890910995
Other versions
EP0391997A1 (en
Inventor
Theodorus Antonius Aloisius Dopheide
Maurice Joseph Frenkel
Warwick Norman Grant
Keith William Savin
Barry Maxwell Wagland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Inhibin Pty Ltd
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Biotechnology Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Biotechnology Australia Pty Ltd filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to EP92203892A priority Critical patent/EP0540128B1/en
Publication of EP0391997A1 publication Critical patent/EP0391997A1/en
Publication of EP0391997A4 publication Critical patent/EP0391997A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19890910995 1988-09-26 1989-09-26 Vaccine Withdrawn EP0391997A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP92203892A EP0540128B1 (en) 1988-09-26 1989-09-26 Nematode vaccine

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
AUPJ062388 1988-09-26
AU623/88 1988-09-26
AUPJ062188 1988-09-26
AU624/88 1988-09-26
AUPJ062488 1988-09-26
AU622/88 1988-09-26
AU621/88 1988-09-26
AUPJ062288 1988-09-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP92203892A Division EP0540128B1 (en) 1988-09-26 1989-09-26 Nematode vaccine

Publications (2)

Publication Number Publication Date
EP0391997A1 EP0391997A1 (en) 1990-10-17
EP0391997A4 true EP0391997A4 (en) 1992-01-15

Family

ID=27424248

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890910995 Withdrawn EP0391997A4 (en) 1988-09-26 1989-09-26 Vaccine

Country Status (4)

Country Link
EP (1) EP0391997A4 (en)
JP (1) JPH03503054A (en)
NZ (1) NZ230773A (en)
WO (1) WO1990003433A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225295A (en) * 1987-07-07 1991-07-26 Biotech Australia Pty Ltd Nematode antigen, its production and vaccines containing it
DE4192335C2 (en) * 1990-09-18 1996-02-08 Biotech Australia Pty Ltd New T-cell epitope(s) derived from the TraT protein of E.Coli
JPH05507208A (en) * 1991-02-06 1993-10-21 バイオテク　オーストラリア　プロプライエタリー　リミテッド nematode vaccine
US5525508A (en) * 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine
US6419923B1 (en) * 1991-02-12 2002-07-16 Heska Corporation Filariid nematode cysteine protease proteins, and uses thereof
US6099843A (en) * 1991-02-12 2000-08-08 Heska Corporation Parasitic helminth PLA2 proteins
US6673916B1 (en) 1991-02-12 2004-01-06 Colorado State University Research Foundation Compositions of parasitic helminth PLA2 nucleic acid molecules and uses thereof
US6060281A (en) * 1991-02-12 2000-05-09 Heska Corporation Parasitic helminth PLA2 proteins and nucleic acid molecules
US5804200A (en) * 1991-02-12 1998-09-08 Colorado State University Research Foundation Parasitic nematode proteins and vaccines
US6150125A (en) * 1991-12-13 2000-11-21 Heska Corporation Flea protease proteins and uses thereof
US6210920B1 (en) 1991-12-13 2001-04-03 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
US5962257A (en) * 1991-12-13 1999-10-05 Heska Corporation Flea aminopeptidase nucleic acid molecules
US6146870A (en) * 1991-12-13 2000-11-14 Heska Corporation Flea protease proteins
US5712143A (en) * 1991-12-13 1998-01-27 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
US6121035A (en) * 1991-12-13 2000-09-19 Heska Corporation Flea aminopeptidase proteins and uses thereof
US5766609A (en) * 1991-12-13 1998-06-16 Heska Corporation Use of protease inhibitors and protease vaccines to protect animals from flea infestation
US5972645A (en) * 1991-12-13 1999-10-26 Heska Corporation Flea serine protease nucleic acid molecules
US6156556A (en) * 1991-12-13 2000-12-05 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
GB9209993D0 (en) 1992-05-08 1992-06-24 Munn Edward A Vaccines
GB9312324D0 (en) * 1993-06-15 1993-07-28 Pitman Moore Inc Vaccine
US6214579B1 (en) 1994-10-18 2001-04-10 Heska Corporation Flea leucine aminopeptidase nucleic acid molecules and uses thereof
US6139840A (en) * 1995-10-18 2000-10-31 Heska Corporation Methods of eliciting an antibody response using flea protease proteins and homologs thereof
US6204010B1 (en) 1995-06-07 2001-03-20 Heska Corporation Flea protease proteins, nucleic acid molecules, and uses thereof
IL120704A0 (en) * 1996-04-24 1998-04-05 Heska Corp Flea protease proteins nucleic acid molecules and uses thereof
US6248872B1 (en) * 1996-12-03 2001-06-19 Heska Corporation Parasitic nematode transglutaminase, nucleic acid molecules, and uses thereof
AUPS021402A0 (en) 2002-01-30 2002-02-21 Agresearch Limited Novel monoclonal antibody and nematode larval antigens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1232849A (en) * 1983-12-01 1988-02-16 The Washington University Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
US4842999A (en) * 1986-08-11 1989-06-27 Adi Diagnostics Inc. Canine heartworm vaccine and diagnostic test
AU618546B2 (en) * 1987-07-07 1992-01-02 Biotechnology Australia Proprietary Limited Vaccines against animal parasitic nematodes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, vol. 80, abstract no. 61135; P. J. HOTEZ et al.: "Isolation and characterization of a proteolytic enzyme from the adult hookworm ***ancylostoma*** - caninum", & J. BIOL. CHEM. 260(12), 1985, 7343-7348 *
CHEMICAL ABSTRACTS, vol. 107, no. 17, 1985, abstract no. 149890a, Columbus, Ohio, US; P. J. HOTEZ: "Identification, isolation, and molecular cloning of a hookworm protease: an approach towards a defined vaccine for ancylostomiasis", & DISS. ABSTR. INT. B 1987, 47(10), 4145 *
CHEMICAL ABSTRACTS, vol. 81, no. 13, 1974, abstract no. 76156y, Columbus, Ohio, US; A. PERRUDET-BADOUX et al.: "Isolation and properties of a soluble antigen of Trichinella spiralis", & IMMUNOLOGY, 26(6), 1217-23 *
CHEMICAL ABSTRACTS, vol. 99, no. 17, 1983, abstract no. 137907q, Columbus, Ohio, US; K. SUGANE et al.: "Purification and characterization of excretory and secretory antigen of Toxocara canis larvae", & IMMUNOLOGY, 50(1), 113-20 *
See also references of WO9003433A1 *

Also Published As

Publication number Publication date
JPH03503054A (en) 1991-07-11
NZ230773A (en) 1993-04-28
WO1990003433A1 (en) 1990-04-05
EP0391997A1 (en) 1990-10-17

Similar Documents

Publication Publication Date Title
GB8907914D0 (en) Vaccine preparation
EP0391997A4 (en) Vaccine
EP0256878A3 (en) Vaccines
ZA88149B (en) Anti-reproductive vaccines
GB8921470D0 (en) Vaccines
GB8702691D0 (en) Vaccines
KR970007376B1 (en) Coccidiosis vaccine
ZW22487A1 (en) Vaccine
ZA874847B (en) Oncornavirus vaccines
GB8815560D0 (en) Improved last
GB8704647D0 (en) Vaccine
GB8819836D0 (en) Vaccine
GB8615068D0 (en) Vaccines
GB8912496D0 (en) Vaccines
EP0453452A4 (en) Vaccine
IE882054L (en) Vaccine
GB8805603D0 (en) Vaccine
GB8810807D0 (en) Vaccines
GB8804688D0 (en) Vaccines
IE880831L (en) Vaccines
GB8605646D0 (en) Vaccines
GB8922651D0 (en) Vaccine
GB8712685D0 (en) Vaccine
IE892784L (en) Vaccines
GB8914532D0 (en) Vaccines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900521

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH O

Owner name: BIOTECHNOLOGY AUSTRALIA PTY. LTD.

A4 Supplementary search report drawn up and despatched

Effective date: 19911127

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920529

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19930206